Slowdown in world's No. 2 economy is weighing on stocks. Outlook Strategies China may pressure stocks for some time
Mergers are driving up biotech stocks, but beware of short traders. Outlook Biotech stocks? Proceed with caution
Americans have reasons to spend in confidence next year. Strategies U.S. growth looks robust heading into 2015
Biotech stocks tend to outperform in times of economic expansion. Strategies Why I added Amgen and Celgene to my portfolio
Here's a look at my ETF strategy heading into the new year. Strategies 2014 ETF strategy: industrials, healthcare and consumer brands
Healthcare reform will bring more patients and boost profits. Strategies Healthcare poised for growth under Obamacare
We did some housecleaning in the Health Care portfolio. Strategies Reshuffling the lineup for my Healthcare portfolio
If we see evidence of some major sectors turning to the upside, we will consider pressing more long trades in our model. Strategies With market risks rising, we’re staying cautious
I added Amgen to the model due to its underlying fundamental and technical strength. Strategies The Covestor health care model is in great shape